According to the National Alliance on Mental Illness 1 in 5 adults (46.6 million) experiences mental illness in a given year. With that number steadily increasing every year it is vital that we invest into new drug discoveries as treatment options. At present the number of drugs available to treat individual with psychiatric disorders varies widely, and it is crucially important to identify new therapeutic targets in order to develop new, effective drugs. Therapeutic Discovery in Psychiatry aims to provide researchers with a complete guide to new technologies and techniques that can effectively manage risk and deliver of new drugs for psychiatric disorders. This book not only addresses issues of reproducibility, but addresses other topics including, drug profiling in vitro, examining drug targets, brain circuits and behavior, medicinal chemistry, drug formulation and pharmacokinetics, and much more. Therapeutic Discovery in Psychiatry is a prime resource for researchers who are trying to understand the field of psychopharmacology.

• Provides a comprehensive guide to developing new drugs for psychiatric disorders
• Discusses technologies and techniques for choosing drug targets
• Presents criteria for what makes a compound worth testing
• Addresses medicinal chemistry, pharmacokinetics, and biomarkers of drug action
• Contains clinical trial design including reproducibility and safety pharmacology
• Reviews next steps including patents, venture capital, business development, and licensing